Trial intelligence / Profile preview

Dose-finding Study of MVA-BN Smallpox Vaccine in Healthy Subjects

NCT00189956Phase 2Completed

Sponsor
Bavarian Nordic
Start
Apr 2003
Primary completion
Nov 2003
Modality
Live Attenuated Vaccines
Countries
1
01

Overview

A Phase 2 trial of JYNNEOS in smallpox, sponsored by Bavarian Nordic. Started Apr 2003; status: completed.

02

Drugs

JYNNEOS
03

Conditions

smallpox

Beyond the preview

Go deeper on NCT00189956.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00189956.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call